Chemical Formula: C19H35NO2

Chemical Formula C19H35NO2

Found 14 metabolite its formula value is C19H35NO2

Dicyclomine

2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylic acid

C19H35NO2 (309.266765)


Dicyclomine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms. [PubChem]Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Allopumiliotoxin 309D

Allopumiliotoxin 309D

C19H35NO2 (309.266765)


   

2-amino-9-methyloctadeca-4,8,10-triene-1,3-diol

2-amino-9-methyloctadeca-4,8,10-triene-1,3-diol

C19H35NO2 (309.266765)


   
   

(8S,Z)-6-((2R)-6-hydroxy-2,5-dimethyloctylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R)-6-hydroxy-2,5-dimethyloctylidene)-8-methyloctahydroindolizin-8-ol

C19H35NO2 (309.266765)


   

(7R,8R,E)-6-((2R)-2,5-dimethyloctylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((2R)-2,5-dimethyloctylidene)-8-methyloctahydroindolizine-7,8-diol

C19H35NO2 (309.266765)


   

(7R)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)octane-2,3-diol

(7R)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)octane-2,3-diol

C19H35NO2 (309.266765)


   

(1S,Z)-3-((2R)-5-hydroxy-2,4-dimethylheptylidene)-1-methyloctahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R)-5-hydroxy-2,4-dimethylheptylidene)-1-methyloctahydro-2H-quinolizin-1-ol

C19H35NO2 (309.266765)


   

9-methyl-sphinga-4E,8E,10E-trienine

9-methyl-sphinga-4E,8E,10E-trienine

C19H35NO2 (309.266765)


   

SPB 19:3;O2

9-methyl-sphinga-4E,8E,10E-trienine

C19H35NO2 (309.266765)


   

(9Z,12Z)-N-(2-hydroxyethyl)heptadeca-9,12-dienamide

(9Z,12Z)-N-(2-hydroxyethyl)heptadeca-9,12-dienamide

C19H35NO2 (309.266765)


   

dicyclomine

dicyclomine

C19H35NO2 (309.266765)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

(9Me,4E,8E,10E-d19:3)sphingosine

(9Me,4E,8E,10E-d19:3)sphingosine

C19H35NO2 (309.266765)


   

(9Me,4E,8E,10E-d19:3) Sphingosine

(9Me,4E,8E,10E-d19:3) Sphingosine

C19H35NO2 (309.266765)